RESEARCH TRIANGLE PARK, NC (RTP) – March 22, 2017 – Dignify Therapeutics, LLC, a leading developer of therapies for bladder and bowel dysfunction, announced that Michael Camilleri, M.D. has joined Dignify’s scientific advisory board. Dr. Camilleri is currently Professor of Medicine and Physiology at the Mayo Clinic School of Medicine in Rochester, Minn. and also…
RESEARCH TRIANGLE PARK, NC (RTP) – October 11, 2016 – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, received three NIH SBIR/STTR grants in the third quarter totaling $3.1 million. The grants were awarded by the National Institute of…
Dignify Therapeutics’ Chief Scientific Officer, Karl B. Thor, PhD, has been invited to participate as a Faculty member at the 2nd International Congress on Underactive Bladder – CURE-UAB in Denver, CO, Dec. 3-4, 2015. His presentation is entitled “Pharmaceutical Targets for Drug-induced Voiding”. This NIH-sponsored congress brings together academic, pharmaceutical, and medical device experts to…
RESEARCH TRIANGLE PARK, NC (RTP) – February 4, 2015 – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, today announced the completion of a $3.15 million equity financing. RA Capital Management, Eshelman Ventures LLC and Terry Engel, an…
RESEARCH TRIANGLE PARK, NC (RTP) – February 3, 2015 – Dignify Therapeutics, LLC, announced that Michael Jay, PhD, and Kristy Borawski, MD, have joined Dignify’s scientific advisory board. Dr. Jay is the Fred Eshelman Distinguished Professor of Molecular Pharmaceutics, and Division Chair at the Eshelman School of Pharmacy at University of North Carolina, Chapel Hill….
RESEARCH TRIANGLE PARK, NC–(January 5, 2015) – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, has received a $250,000 Small Business Research Loan (SRL) from the North Carolina Biotechnology Center. The loan supports preclinical development of Dignify’s lead…
RESEARCH TRIANGLE PARK, NC (RTP) – November 4, 2014 – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, has received a $50,000 grant from the North Carolina Office of Science, Technology & Innovation’s One North Carolina Small Business…
RESEARCH TRIANGLE PARK, NC (RTP) – August 15, 2014 – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant in the amount of $159,000 from the Eunice…
In August 2012, Troy Russell, a scholar athlete, broke two vertebrae in his neck in a diving accident at a Narragansett, RI beach. The break in his neck resulted in an initial loss of mobility to his legs and arms. Over time and through a lot of hard work, Troy has improved physically. Today, he…
RESEARCH TRIANGLE PARK, NC – May 5, 2014 – Dignify Therapeutics, a drug development company focused on developing novel bladder and bowel drug therapies for patients with spinal conditions, today announced that it has become a member of the Blackstone Entrepreneurs Network (BEN). Blackstone Companies come from across the region and are selected through a…